Fed tapering would be a positive for stocks, UBS Chief Equity Strategist Jeremy Zirin says.» Read More
After offering $210 million for Playboy Enterprises, Penthouse parent FriendFinder Networks CEO Marc Bell told Fast Money why he wants to get into bed with Hugh Hefner.
Joe Terranova has been very bullish on Anadarko, but says it's time to move on. What's changed?
The Fast Money traders expect the Street will scramble to buy a slew of names in the wake of Intel's report. What should be on your radar?
New data suggests shorts have fled stocks ahead of earnings. Does that suggest the only place to go is up?
An analyst at Wells Fargo lowered estimates for Goldman and Morgan Stanley Tuesday, the 8th analyst to do so since June 4th. Why so long?
We spoke with this bank CEO, who expects profits to double in the next three years.
Ahead of earnings season, how should you balance broad economic headwinds against what may be attractive single stock stories?
In midday trading, stocks inched higher for a fourth day Friday, putting the markets on-track for the best week of trading in more than a year.
Prepare for a deluge of earnings reports next week. Some of the most widely followed companies will all release results one after another. How should you position?
Our Fast Money traders are looking at the fundamentals of individual stocks—here's their faves!
With stocks paring early gains, are key technical levels more likely to provide support or resistance?
Bill Fleckenstein of Fleckenstein Capital thinks tech names will soon pick-up, so how's he playing it?
Once again the traders are closely watching 1040 as a key level on the S&P. If the market closes above it, should you start buying?
One energy name gets an upgrade and the analyst who made the call explains why he likes this space.
A triple digit gain in the Dow couldn't ignite bullish sentiment on the Fast Money desk. The traders remained skeptical of Tuesday’s rally.
Try to enjoy the holiday because Joe Terranova thinks Tuesday morning could be pretty nasty. Find out why he's bracing for a capitulation sell-off!
Which pharmaceutical company is reportedly preparing to spend $20 billion for a US drug maker?
The CEO of this giant toy maker discusses his company's outlook with the Fast Money traders. Should you 'play games' with your portfolio?
The S&P is now on the verge of a technical pattern called a death cross. As the name implies the formation is very bearish. How far will stocks fall?
Why the big money name thinks construction of the "relief" well is ahead of schedule.
Missed an episode of Fast Money? Watch the latest show here.
Sign up for our daily newsletter!
Download Fast Money onto your MP3 Player.